Schedule 13D ownership disclosure

VERRICA PHARMACEUTICALS INC

Common Stock, $0.0001 par value per share · CUSIP: 92511W207

Event date: 2025-11-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Paul B ManningReported CIK 0001494695

    Shares: 8,056,031.00 · Class: 49.9%

  • PBM Capital Investments, LLC

    Shares: 25,663.00 · Class: 0.2%

  • BKB Growth Investments, LLC

    Shares: 3,348,372.00 · Class: 20.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001494695-25-000006
Form type
SCHEDULE 13D/A
Filer
Manning Paul B
CIK
CIK 1494695
Filed
Nov 28, 2025
Reporting period
Nov 25, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub